Delivery Order SPE2DB22D2007-SPE2DB25FJ1EE

Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,259.50, is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product, with a total ceiling value of $26,519.00. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This federal contract award, valued at $24,304.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug product SCEMBLIX 40 MG TABLET. It is a firm-fixed-price contract with a completion date of November 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $13,259.50 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic drugs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,293.82 firm fixed-price delivery order is for the supply of SCEMBLIX 20 MG TABLET UU 60S, a medical product, with a period of performance through December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,646.91 firm fixed-price delivery order is for pharmaceutical product SCEMBLIX 20 MG TABLET UU 60S, with a completion date of January 15, 2025. Amerisourcebergen is a major pharmaceutical distributor that is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The award is not associated with a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,869.37 and is for the provision of SCEMBLIX 40 MG TABLET medication. The contract has a firm fixed price structure and an ultimate completion date of June 2, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type, a ceiling value of $46,746.18, and a performance period through May 1, 2025. The contract is not set aside and is for the provision of pharmaceutical products and medical supplies to support federal medical and healthcare programs, particularly for the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of pharmaceutical products and medical supplies. The contract has a total ceiling value of $19,110.00 and is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is May 1, 2025. The contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $48,123.97 and a performance period ending on May 1, 2025, is for the supply of a range of pharmaceutical products and medical supplies to support military and government healthcare programs. Amerisourcebergen...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1EE
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $13,259.50. The award is for the pharmaceutical product SCEMBLIX 40 MG TABLET UU 60S, with a performance period ending on May 23, 2025. This contract is not designated as a set-aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard, among others.

Generated 8/3/25, 1:14 AM